Agenda
13:30 - 14:00
Registration and networking - welcoming drinks and professional head shots for attendees.
14:00 - 14:20
Introduction and Welcome
Speaker Name
Speaker TitleSpeaker Name
Speaker Title15:00 - 15:30
Q&A and first prize draw
Speaker Name
Speaker Title
Kent Thoelke
Executive Vice President and Chief Medical OfficerPRA Health Sciences
Mr Thoelke provides scientific and strategic oversight of product development and directs the following PRA divisions: Medical Affairs, Scientific Affairs, Site Intelligence & Early Engagement, Medical Informatics, Patient Engagement, and the infectious diseases and vaccines group. He has more than 21 years of experience in the global drug development, diagnostic, and device industry, offering specialized expertise in global hematology/oncology studies. Having visited over 40 countries, he is familiar with the global drug development environment and has established relationships with therapeutic experts in numerous indications around the world. Mr Thoelke has spoken widely about the current landscape of clinical trial recruitment and drug development timelines. He actively pursues novel technologies and strategies to move the current clinical drug development paradigm toward a more evidence-based strategy. A leader in the field of medical informatics, Mr Thoelke focuses on leveraging data to maximize patient enrollment by selecting high-performing sites to minimize overall drug development timelines. He is a named inventor on numerous patents in high-dose radiotherapy for the treatment of hematologic malignancies that ultimately developed into a therapeutic product.
Refreshments
Speaker Name
Speaker Title15:30 - 16:00
The Future of Clinical Trials
Keris Huang
Speaker Name
Speaker Title11:00 - 11:15
15 minutes
Refreshments
Speaker Name
Speaker Title16:00-16:45
Q&A and 2nd prize draw
Speaker Name
Speaker TitleSpeaker Name
Speaker TitleSpeaker Name
Speaker Title16:45-17:00
Networking with PRA and afternoon tea
Keris Huang
Clinical Research Director of Global Clinical Trial OperationsMerck Sharp and Dohme
Keris Huang is the Clinical Research Director of Global Clinical Trial Operations in Merck Sharp & Dohme and is responsible for both Taiwan and Hong Kong. She has been in the industry for around 20 years, started her career as a clinical pharmacist and worked as various roles in clinical research in major pharma such as MSD and Eli Lilly. She has extensive regional experience, including a 6 months assignment in Japan. Keris is also actively involved in different organizations in supporting clinical research development in Taiwan, she acted as the President of Taiwan Clinical Research Association from Jun 2013 to Aug 2015 and now is the AP sub-team lead for TransCelerate eLabel Workstream.
SungIn Hong
VP Strategic Solutions, APACPRA Health Sciences
SungIn Hong is a Vice President, Strategic Solutions division in the Asia-Pacific region that includes Australia, China/HongKong, India, Malaysia, New Zealand, Philippines, Singapore, S. Korea, Taiwan, and Thailand.
Ms Hong is based in Seoul, S. Korea and is responsible for overseeing global/regional embedded programs as well as establishing appropriate regional infrastructure to support operations across the region.
She has MSc degree in Pharmacology, Drug Delivery System and approximately 20 years of industry experience including both multinational pharma and CRO companies that spans across clinical operations, regulatory affairs and project management.
Prior to PRA, Ms Hong worked for another large CRO and was successfully setting up the infrastructure across the region by developing AP team in the hiring and training process, supporting business development activities and managing projects directly in alignment with global strategy.
Jon Newton, MBA
Executive Director, Clinical Operations, Asia PacificPRA Health Sciences
Jon joined PRA in 2010 as a Director of Project Management based in the UK. He moved into the Director of Project Delivery role and in 2013 relocated to Singapore to take on the position of Senior Director for Clinical Operations in AsiaPac to further support PRA’s expanding presence in the region. He has now taken on the role of Executive Director, Clinical Operations, AsiaPac.
Jon joined the CRO industry in 1998 and has held many positions throughout his career in which he has participated in hiring and resourcing of staff, delivered and developed departmental training, supported business development with proposal development and client management, engaged in process and policy development, and provided performance management for a global team as a functional manager.
Jon holds a Bachelor of Science degree in Business and Human Resource Management as well as a Master of Business Administration focused on Health Care Management.
Sarah Liao
Director of Clinical OperationsPRA Health Sciences
Sarah Liao, Director of Clinical Operations, joins PRA since 2004 and has more than 17 years of clinical research experiences this far. With background of DVM and 2 MS in Immunology and Epidemiology respectively, she started her career in Clinical Research as Clinical Research Associate, Clinical Research Manager and now Director of Clinical Operations, in regional/global CROs and Global Pharmaceutical Company. She has countries experiences of office set up, studies conduction and team management in Taiwan, Hong-Kong, Philippine, Singapore, Thailand and China as well as working with international partner in Malaysia, China, and Vietnam in the region. She is a member of PRAHS Clinical Quality Initiative focusing on quality delivery. She also support/participate regulatory inspection, sponsor/3rd party audit and internal office audit in responsible countries. Therapeutic experiences in Radiology, Osteopaedics, Respiratory, Oncology, hematology, Cardiovascular, Metabolism disease, Infectious Disease and CNS. Sarah is based in Taipei, Taiwan.
